Understanding and targeting cancer stem cells represents a
revolutionary, game-changing prospect for the pharmaceutical and biotech industry.
The world`s first and only commercially-focussed
Cancer Stem Cells 2010 meeting provides a unique opportunity for oncology business/research leaders and scientists to assess the potential of cancer stem cells for your business and research.
And for those companies and people already focussing on cancer stem cells, this
is the world`s largest and best industry-focused event where you can meet the people and companies making it happen.
Why attend? - Understand efforts of big pharma and large biotech companies like Pfizer, Genentech, MedImmune, Novartis, Bristol-Myers Squibb, Merck, AstraZeneca and Roche in targeting cancer stem cells
- Listen to the world`s most innovative biotechs such as OncoMed, Geron, Stemline Therapeutics, ImmunoCellular Therapeutics, Micromet, Fate Therapeutics and Cellerant Therapeutics outline how they are attacking or preventing cancer stem cells from taking hold, along with the very latest clinical updates
- Hear pioneering research leaders and scientists, including Dr Robert Weinberg of the Whitehead Institute and Dr Piyush Gupta of the Broad Institute
- Get critical perspectives on your research from the brightest minds working in the cancer stem cells field
- Build an unrivalled network of contacts all researching and developing drugs targeting cancer stem cells.
